Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-611
Closed -$130K 1188
2021
Q4
$130K Sell
611
-25
-4% -$4.93K ﹤0.01% 457
2021
Q3
$96K Hold
636
﹤0.01% 487
2021
Q2
$92K Buy
636
+25
+4% +$3.18K ﹤0.01% 491
2021
Q1
$76K Buy
611
+461
+307% +$61.5K ﹤0.01% 530
2020
Q4
$21K Sell
150
-140
-48% -$18.2K ﹤0.01% 766
2020
Q3
$30K Buy
290
+140
+93% +$14.4K ﹤0.01% 663
2020
Q2
$15K Sell
150
-90
-38% -$7.98K ﹤0.01% 711
2020
Q1
$19K Hold
240
﹤0.01% 661
2019
Q4
$23K Buy
240
+50
+26% +$4.7K ﹤0.01% 705
2019
Q3
$18K Buy
190
+100
+111% +$10.9K ﹤0.01% 744
2019
Q2
$11K Buy
+90
New +$10.5K ﹤0.01% 815

Other funds holding XLNX

HM Payson & Co's XLNX Position: Q1 2022 in Review

HM Payson & Co sold out of Xilinx Inc (XLNX) in Q1 2022, closing a stake of 611 shares — an estimated $130K sold.

HM Payson & Co first reported a position in XLNX in Q2 2019 and held it in 11 quarters. The position peaked at $130K in Q4 2021. 4 funds tracked by Wall St. Rank hold XLNX as of Q1 2022.

  • HM Payson & Co reported no remaining Xilinx Inc position as of Q1 2022 after selling out during the quarter.
  • HM Payson & Co sold 611 Xilinx Inc shares in Q1 2022, an estimated $130K.
  • HM Payson & Co first reported a position in Xilinx Inc in Q2 2019 and held it in 11 quarters.
  • HM Payson & Co's Xilinx Inc position peaked at $130K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Xilinx Inc as of Q1 2022.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.